Unknown

Dataset Information

0

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.


ABSTRACT: Aneuploidy has been recognized as a hallmark of cancer for more than 100 years, yet no general theory to explain the recurring patterns of aneuploidy in cancer has emerged. Here, we develop Tumor Suppressor and Oncogene (TUSON) Explorer, a computational method that analyzes the patterns of mutational signatures in tumors and predicts the likelihood that any individual gene functions as a tumor suppressor (TSG) or oncogene (OG). By analyzing >8,200 tumor-normal pairs, we provide statistical evidence suggesting that many more genes possess cancer driver properties than anticipated, forming a continuum of oncogenic potential. Integrating our driver predictions with information on somatic copy number alterations, we find that the distribution and potency of TSGs (STOP genes), OGs, and essential genes (GO genes) on chromosomes can predict the complex patterns of aneuploidy and copy number variation characteristic of cancer genomes. We propose that the cancer genome is shaped through a process of cumulative haploinsufficiency and triplosensitivity.

SUBMITTER: Davoli T 

PROVIDER: S-EPMC3891052 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.

Davoli Teresa T   Xu Andrew Wei AW   Mengwasser Kristen E KE   Sack Laura M LM   Yoon John C JC   Park Peter J PJ   Elledge Stephen J SJ  

Cell 20131031 4


Aneuploidy has been recognized as a hallmark of cancer for more than 100 years, yet no general theory to explain the recurring patterns of aneuploidy in cancer has emerged. Here, we develop Tumor Suppressor and Oncogene (TUSON) Explorer, a computational method that analyzes the patterns of mutational signatures in tumors and predicts the likelihood that any individual gene functions as a tumor suppressor (TSG) or oncogene (OG). By analyzing >8,200 tumor-normal pairs, we provide statistical evide  ...[more]

Similar Datasets

| S-EPMC9061794 | biostudies-literature
| S-EPMC7806824 | biostudies-literature
| S-EPMC6063474 | biostudies-literature
| S-EPMC3975662 | biostudies-literature
| S-EPMC3528526 | biostudies-literature
| S-EPMC6643283 | biostudies-literature
| S-EPMC8460028 | biostudies-literature
| S-EPMC5316854 | biostudies-literature
| S-EPMC5881660 | biostudies-literature
| S-EPMC6278861 | biostudies-other